Banana peel extract suppressed prostate gland enlargement in testosterone-treated mice

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 9, 2009, Pages 1911-1914

  Akamine, Kiichiro ^a   Koyama, Tomoyuki ^a   Yazawa, Kazunaga ^a  

^a TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Anti androgen effect; Banana peel extract; Inhibitor of 5alpha reductase; Mice; Suppressive effect on benign prostate hyperplasia

Indexed keywords

ANTI-ANDROGEN EFFECT; BANANA PEEL EXTRACT; INHIBITOR OF 5ALPHA-REDUCTASE; MICE; SUPPRESSIVE EFFECT ON BENIGN PROSTATE HYPERPLASIA;

CELL CULTURE; CELL GROWTH; GROWTH KINETICS; METHANOL;

CELL MEMBRANES;

PLANT EXTRACT; TESTOSTERONE;

ANIMAL; ARTICLE; BANANA; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; MOUSE; PROSTATE; PROSTATE HYPERTROPHY; SEMINAL VESICLE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICE; MUSA; PLANT EXTRACTS; PROSTATE; PROSTATIC HYPERPLASIA; SEMINAL VESICLES; TESTOSTERONE;

MUS;

EID: 70349673580     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80770     Document Type: Article

References (23)

1. Russell DW and Wilson JD, Annu. Rev. Biochem., 63, 25-61 (1994).
2. Cristoni A, Di Pierro F, and Bombardelli E, Fitoterapia, 71, S21-S28 (2000).
3. Lowe FC, McConnell JD, Hudson PB, Romas NA, Boake R, Lieber M, Elhilali M, Geller J, Imperto-McGinely J, Andriole GL, Bruskewitz RC, Walsh PC, Bartsch G, Nacey JN, Shah S, Pappas F, Ko A, Cook T, Stoner E, and Waldstreicher J, Urology, 61, 791-796 (2003).
4. Marks LS, Rev. Urol., 6, S11-S21 (2004).
5. Fagelman E and Lowe FC, Rev. Urol., 3, 134-138 (2001).
6. Proteggente AR, Pannala AS, Paganga G, Van Buren L, Wagner E, Wiseman S, van de Put F, Dacombe C, and Rice-Evans CA, Free Radic. Res., 36, 217-233 (2002).
7. Blades BL, Dufficy L, Englberger L, Daniells JW, Coyne T, Hamill S, and Wills RB, Asia Pac. J. Clin. Nutr., 12, S36 (2003).
8. Yamasaki K, Sawaki M, Ohta R, Okuda H, Katayama S, Yamada T, Ohta T, Kosaka T, and Owens W, Environ. Health Perspect., 111, 1912-1919 (2003).
9. Goldmann WH, Sharma AL, Currier SJ, Johnston PD, Rana A, and Sharma CP, Cell Biol. Int., 25, 1117-1124 (2001).
10. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, and Bullock P, Toxicol. In Vitro, 18, 703-710 (2004).
11. Franck-Lissbrant I, Häggström S, Damber JE, and Bergh A, Endocrinology, 139, 451-456 (1998).
12. Lazier CB, Thomas LN, Douglas RC, Vessey JP, and Rittmaster RS, Prostate, 58, 130-144 (2004).
13. McConnell JD, Wilson JD, George FW, Geller J, Pappas F, and Stoner E, J. Clin. Endocrinol. Metab., 74, 505-508 (1992).
14. Sudduth SL and Koronkowski MJ, Pharmacotherapy, 13, 309-325 (1993).
15. Bergman L and Eriksson E, Acta Psychiatr. Scand., 94, 137-139 (1996).
16. Sundblad C, Landén M, Eriksson T, Bergman L, and Eriksson E, J. Clin. Psychopharmacol., 25, 85-88 (2005).
17. Romijn JC, Verkoelen CF, and Schroeder FH, Prostate, 12, 99-110 (1988).
18. Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, and Vaughan ED, Endocrinology, 131, 1149-1156 (1992).
19. Geller J, Albert J, Nachtsheim DA, Loza D, and Geller S, Prostate, 2, 309-314 (1981).
20. Nakayama O, Hirosumi J, Chida N, Takahashi S, Sawada K, Kojo H, and Notsu Y, Prostate, 31, 241-249 (1997).
21. Happi Emaga T, Robert C, Ronkart SN, Wathelet B, and Paquot M, Bioresour. Technol., 99, 4346-4354 (2008).
22. Oliveira L, Freire CS, Silvestre AJ, and Cordeiro N, J. Agric. Food Chem., 56, 9520-9524 (2008).
23. Hill B and Kyprianou N, Prostate, 61, 73-80 (2004)